UPL Résultats passés
Passé contrôle des critères 2/6
Les bénéfices de UPL ont diminué à un taux annuel moyen de -31.8%, tandis que le secteur Chemicals a vu ses bénéfices augmenter de en à 7.2% par an. Les revenus ont augmenté de en à un taux moyen de 2.7% par an. Le rendement des capitaux propres de UPL est 5.3% et ses marges nettes sont de 3.3%.
Informations clés
-31.81%
Taux de croissance des bénéfices
-31.44%
Taux de croissance du BPA
| Chemicals Croissance de l'industrie | 17.68% |
| Taux de croissance des recettes | 2.71% |
| Rendement des fonds propres | 5.32% |
| Marge nette | 3.30% |
| Prochaine mise à jour des résultats | 11 May 2026 |
Mises à jour récentes des performances passées
Recent updates
512070: Fair Pricing Will Depend On Execution Of Upcoming Restructuring And Treasury Plans
Analysts have trimmed their price target on UPL from ₹647.56 to ₹630.00, citing updated assumptions around revenue growth, profit margin, discount rate and future P/E that slightly adjust their valuation framework. What's in the News UPL has scheduled a Special or Extraordinary Shareholders Meeting on March 31, 2026, at 15:30 IST to consider and approve material related party transactions for sale of materials and functional support services between UPL and its subsidiaries, and between Arysta LifeScience Benelux SRL and UPL Europe Supply Chain GmbH (Key Developments).
512070: Composite Scheme And Governance Steps Will Support Stronger Medium Term Outlook
Analysts have trimmed their price target on UPL slightly from about ₹820.53 to ₹811.50, reflecting updated assumptions around the discount rate, revenue growth, profit margin and future P/E multiple. What's in the News Board meeting on Feb 20, 2026 to consider a Composite Scheme of Arrangement among UPL Limited and multiple group entities under Sections 230 to 232 and 234 of the Companies Act, 2013, based on recommendations from the Audit Committee and the Committee of Independent Directors (company filing).
512070: Upcoming Governance Decisions And Treasury Scheme Will Support A Stronger Outlook
Analysts have trimmed their price target on UPL from ₹975 to ₹947, citing updated assumptions on long term profit margins and P/E multiples, along with refreshed views on growth, discount rates and fair value. What's in the News UPL has called a Special or Extraordinary Shareholders Meeting for March 31, 2026, at 15:30 IST to seek approval for material related party transactions involving sale of materials and functional support services between UPL and its subsidiaries, and between Arysta LifeScience Benelux SRL and UPL Europe Supply Chain GmbH (Key Developments).512070: Fair Pricing Will Rely On Execution Of Upcoming Restructuring Steps
Analysts have nudged their price target on UPL slightly higher to about ₹648 from roughly ₹641, citing updated assumptions around revenue growth, profit margins, a modestly lower discount rate, and a small adjustment to the expected future P/E multiple. What's in the News UPL has scheduled a board meeting on Feb 02, 2026 at 12:45 Indian Standard Time to consider and approve unaudited consolidated and standalone financial results for the quarter and nine months ended Dec 31, 2025, along with limited review reports from the statutory auditors (Key Developments).512070: Composite Scheme Board Meeting Will Support Stronger Medium Term Outlook
Analysts have raised their price target on UPL by about ₹39 to ₹820, citing updated assumptions that reflect a slightly lower discount rate, a modest tweak to revenue growth and P/E expectations, and a higher projected profit margin. What's in the News Board meeting scheduled for Feb 20, 2026 at 14:30 IST to consider a Composite Scheme of Arrangement involving UPL and its subsidiaries UPL Sustainable Agri Solutions Limited, UPL Global Sustainable Agri Solutions Limited, and UPL Crop Protection Holdings Limited under Sections 230 to 232 and 234 of the Companies Act, 2013 (company filing).512070: Revised Margins And Lower P/E Will Likely Struggle To Support Pricing
Analysts have raised their fair value estimate for UPL from ₹600.67 to ₹641.03, citing updated views on the discount rate, revenue growth, profit margins and future P/E assumptions. What's in the News Board meeting scheduled for Feb 02, 2026, at 12:45 Indian Standard Time to review unaudited consolidated and standalone financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).512070: Higher Margin Assumptions And Upcoming Results Will Support A Stronger Fair Value Outlook
Analysts have raised their fair value estimate for UPL from ₹944 to ₹975, reflecting updated assumptions around discount rate, revenue growth, profit margin, and future P/E expectations. What's in the News UPL has scheduled a board meeting on Feb 02, 2026, at 12:45 Indian Standard Time to review unaudited consolidated and standalone financial results.512070: Higher Revenue And Margin Assumptions Will Support A Stronger Fair Value Outlook
Analysts have raised their fair value estimate for UPL from ₹911.93 to ₹944.00 after updating their assumptions for revenue growth, profit margins, discount rate and future P/E. What's in the News UPL has scheduled a Board Meeting on November 6, 2025 to consider and approve the unaudited consolidated and standalone financial results for the quarter and half year ended September 30, 2025, along with the Limited Review Reports from the statutory auditors (company filing).512070: Small Assumption Tweaks Will Likely Fail To Prevent Margin Pressure
Analysts have slightly increased their fair value estimate for UPL from ₹596.98 to ₹600.67. This reflects small adjustments to assumptions around the discount rate, revenue growth, profit margins and future P/E multiples.512070: Future Margins Will Likely Deteriorate Despite Higher Market Expectations
Analysts have raised their price target for UPL from approximately 526.51 to 596.98, citing slightly stronger expectations for revenue growth and future valuation multiples, partly offset by a more conservative view on profit margins and discount rates. What's in the News UPL Limited has scheduled a board meeting for November 06, 2025 to consider and approve unaudited consolidated and standalone financial results for the quarter and half year ended September 30, 2025, along with the limited review reports from the statutory auditors (company filing).512070: Board Meeting And Stable Assumptions Will Shape Medium Term Outlook
Analysts have modestly raised their price target for UPL to ₹781.39, reflecting slightly improved discount rate and future P E assumptions, while largely maintaining their views on growth and profitability. What's in the News A board meeting is scheduled on November 6, 2025 to consider and approve the unaudited consolidated and standalone financial results for the quarter and half year ended September 30, 2025, along with the Statutory Auditors' limited review reports (company filing).512070: Board Meetings And Adjusted Forecasts Will Influence Medium-Term Outlook
Analysts have raised their price target for UPL from $756.34 to $781.39. This reflects optimism driven by slightly improved revenue growth expectations and adjustments to projected profit margins and valuation multiples.512070: Upcoming Board Decisions And Steady Financials Will Shape Outlook
Analysts have raised their price target for UPL from $736.09 to $756.34. They cite modest improvements in profit margin and revenue growth forecasts as the reason for this adjustment.
Biosolutions Innovation And Improved Financial Stability Expected To Boost Earnings Growth
Strategic inventory management and sales mix enhancement are expected to boost margins and improve earnings.Ventilation des recettes et des dépenses
Comment UPL gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 31 Dec 25 | 490,770 | 16,210 | 67,060 | 0 |
| 30 Sep 25 | 477,150 | 20,530 | 64,270 | 0 |
| 30 Jun 25 | 467,860 | 10,570 | 63,360 | 0 |
| 31 Mar 25 | 466,370 | 7,610 | 62,460 | 0 |
| 31 Dec 24 | 451,420 | -950 | 58,910 | 0 |
| 30 Sep 24 | 441,220 | -21,400 | 58,950 | 0 |
| 30 Jun 24 | 432,020 | -18,860 | 56,950 | 0 |
| 31 Mar 24 | 430,980 | -13,360 | 55,740 | 0 |
| 31 Dec 23 | 455,890 | -5,830 | 61,940 | 0 |
| 30 Sep 23 | 493,810 | 17,210 | 63,540 | 0 |
| 30 Jun 23 | 517,180 | 27,240 | 63,480 | 0 |
| 31 Mar 23 | 535,760 | 34,350 | 63,220 | 0 |
| 31 Dec 22 | 528,680 | 40,360 | 60,120 | 0 |
| 30 Sep 22 | 504,860 | 38,850 | 58,240 | 0 |
| 30 Jun 22 | 485,460 | 37,050 | 56,780 | 0 |
| 31 Mar 22 | 462,400 | 35,050 | 53,940 | 0 |
| 31 Dec 21 | 431,750 | 32,200 | 47,520 | 0 |
| 30 Sep 21 | 410,040 | 30,780 | 46,110 | 0 |
| 30 Jun 21 | 393,760 | 29,070 | 44,290 | 0 |
| 31 Mar 21 | 386,940 | 27,810 | 43,570 | 0 |
| 31 Dec 20 | 370,390 | 24,250 | 44,650 | 0 |
| 30 Sep 20 | 368,050 | 23,390 | 41,930 | 0 |
| 30 Jun 20 | 356,830 | 20,420 | 34,000 | 0 |
| 31 Mar 20 | 357,560 | 17,760 | 40,910 | 0 |
| 31 Dec 19 | 331,400 | 13,650 | 36,440 | 0 |
| 30 Sep 19 | 291,690 | 9,340 | 34,170 | 0 |
| 30 Jun 19 | 256,090 | 11,150 | 25,020 | 0 |
| 31 Mar 19 | 218,370 | 14,910 | 26,050 | 0 |
| 31 Dec 18 | 190,030 | 19,770 | 22,390 | 0 |
| 30 Sep 18 | 182,760 | 20,900 | 21,600 | 0 |
| 30 Jun 18 | 177,890 | 20,590 | 21,390 | 0 |
| 31 Mar 18 | 173,780 | 20,220 | 20,970 | 0 |
| 31 Dec 17 | 170,290 | 20,270 | 21,470 | 0 |
| 30 Sep 17 | 167,540 | 19,120 | 21,450 | 0 |
| 30 Jun 17 | 165,250 | 18,400 | 20,980 | 0 |
| 31 Mar 17 | 163,120 | 17,270 | 20,610 | 0 |
| 31 Dec 16 | 146,180 | 15,473 | 17,197 | 0 |
| 30 Sep 16 | 140,163 | 13,692 | 16,477 | 0 |
| 30 Jun 16 | 135,366 | 13,840 | 15,884 | 0 |
| 31 Mar 16 | 140,480 | 9,400 | 18,170 | 0 |
| 31 Dec 15 | 125,861 | 11,913 | 23,977 | 37 |
| 30 Sep 15 | 125,370 | 11,538 | 23,595 | 37 |
| 30 Jun 15 | 123,978 | 11,347 | 23,357 | 37 |
Des revenus de qualité: 512070 a des bénéfices de haute qualité.
Augmentation de la marge bénéficiaire: 512070 est devenu rentable dans le passé.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: Les bénéfices de 512070 ont diminué de 31.8% par an au cours des 5 dernières années.
Accélération de la croissance: 512070 est devenu rentable au cours de l'année dernière, ce qui rend le taux de croissance des bénéfices difficile à comparer à sa moyenne sur 5 ans.
Bénéfices par rapport au secteur d'activité: 512070 est devenue rentable au cours de l'année dernière, ce qui rend difficile la comparaison de sa croissance des bénéfices de l'année écoulée avec celle du secteur Chemicals ( 8.7% ).
Rendement des fonds propres
ROE élevé: Le retour sur capitaux propres de 512070 ( 5.3% ) est considéré comme faible.
Rendement des actifs
Rendement des capitaux employés
Découvrir des entreprises performantes dans le passé
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/05 21:15 |
| Cours de l'action en fin de journée | 2026/05/05 00:00 |
| Les revenus | 2025/12/31 |
| Revenus annuels | 2025/03/31 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
UPL Limited est couverte par 46 analystes. 18 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| null null | 360 ONE Capital Market Private Limited |
| Himanshu Binani | Anand Rathi Shares and Stock Brokers Limited |
| null null | Anand Rathi Shares and Stock Brokers Limited |